Blog footer

Digital Pharma: Mobile app regulation

July 21, 2011
Medical Communications, Sales and Marketing Digital Phama blog, app, ipad, iphone, mobile

The FDA has proposed new rules for smartphone apps, but says the guidelines will only apply to a small number …

Service Insight: Logical logistics

July 21, 2011
Manufacturing and Production Service Insight, manufacturing and production

SERVICE INSIGHTThere is no mistaking that we have been faced with turbulent times over the last year or so and …

AZ's Brilinta (ticagrelor)

FDA approves AstraZeneca’s Brilinta after delay

July 21, 2011
Sales and Marketing AstraZeneca, Brilinta, Brilique, antiplatelet

The FDA has finally approved AstraZeneca’s oral blood thinner Brilinta after asking for more information on the drug last year.  …

MSI appoints new managing director

July 21, 2011
Sales and Marketing appointment, sales and marketing

UK-based pharmaceutical consultancy the MSI Consultancy has appointed Jon Bircher as managing director. He joined MSI in January 2006 from …

Eli Lilly & Co

Lilly presents data on failed Alzheimer’s candidate

July 21, 2011
Research and Development Alzheimer's disease, lilly, research and development news, semagacestat

Lilly has presented a review of data from semagacestat, the Alzheimer’s drug it dropped last year after disappointing results. Phase …

AZ adds new heart warning to Seroquel

July 21, 2011
Sales and Marketing Seroquel, antipsychotic

AstraZeneca has added a new heart warning to the packaging on its antipsychotic drug Seroquel at the behest of the …

Merck signs major deal with China’s Simcere

July 21, 2011
Sales and Marketing Merck, Simcere, emerging markets

Merck is to establish a joint venture with China’s Simcere focused on serving China’s rapidly expanding health care needs by …

Moorfields Pharmaceuticals and MC2 Biotek Group enter into a collaboration and licence agreement to develop new ophthalmic products

July 20, 2011
Manufacturing and Production

Moorfields Pharmaceuticals and MC2 Biotek have signed a collaboration and licence agreement concerning development of novel ophthalmic products addressing unmet …

NICE says no to breast cancer treatment Halaven

July 20, 2011
Sales and Marketing Eisai, Halaven, NICE

Eisai’s Halaven has been rejected by NICE in draft guidance for locally advanced or metastatic breast cancer. Halaven (eribulin) is …

Analysis paralysis – how to get the true measure of clinical trials

July 20, 2011
Research and Development Les Rose, clinical trials

The great physicist Lord Kelvin famously said: “When you can measure what you are speaking about, and express it in …

Future of AZ-BMS diabetes drug in doubt

July 20, 2011
Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes, research and development news

A US advisory committee has rejected an investigational compound for type II diabetes sufferers, throwing its future into doubt. Dapagliflozin, …

MSD's Victrelis (boceprevir)

Hep C drug Victrelis gains EU approval

July 20, 2011
Sales and Marketing Incivek, Victrelis, hepatitis C

Merck Sharp & Dohme’s Victrelis, one of two major new hepatitis C drugs, has gained final approval in Europe. Victrelis …

Contract research news in brief

July 20, 2011
Research and Development research and development news

M&A abounds in the CRO sector with INC completing its purchase of Kendle, inVentiv snappig up Pharmanet and ICON buying …

Government seeks to salvage pharma pricing reforms

July 19, 2011
Sales and Marketing NICE, value-based pricing

The government is pushing ahead with plans to introduce value-based pricing in 2014, despite acknowledging the new system still requires …

Victrelis

Hepatitis C rivals go head to head

July 19, 2011
Sales and Marketing Incivek, Incivo, Victrelis, boceprevir, hepatitis C, telaprevir

 The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …

Novartis

Novartis posts double-digit sales and profit growth

July 19, 2011
Sales and Marketing Novartis

Novartis had a strong second quarter of the year, with both sales and profit up on the same period in …

In search of authenticity

July 19, 2011
Sales and Marketing

We don’t have a sales consultant in front of us in that situation. There is nobody to demonstrate and reassure …

Sweden seeks GMP revisions to tackle environmental pollution

July 19, 2011
Manufacturing and Production pharma manufacturing news

Wholesale shifting of pharmaceutical production to low-cost countries such as India and China is creating environmental impacts “on a scale …

Lonza wins another antibody contract

July 19, 2011
Manufacturing and Production Immune Pharmaceuticals, Lonza, pharma manufacturing news

Lonza has won a contract to manufacture Immune Pharmaceuticals’ antibody-based drug for inflammatory disorders, bertilimumab, at its mammalian development and …

New joint venture plans to tap into global generics market

July 19, 2011
Ajinomoto OmniChem, Granules India, pharma manufacturing news

Belgian fine chemicals company Ajinomoto OmniChem has forged a joint venture with Granules India to produce active pharmaceutical ingredients and …

The Gateway to Local Adoption Series

Latest content